These unsuccessful clinical trials call attention to the need for a better understanding of the inflammatory mechanisms driven by TNF-α in HF, so that alternative therapeutic approaches can be developed to counter its adverse effects. The gene discussed is TNF; the disease is hydrops fetalis.